Microbiota modulation-based therapy for luminal GI disorders: current applications of probiotics and fecal microbiota transplantation. (2nd December 2019)

• Record Type: Journal Article
• Authors: Elangovan, Abbinaya; Allegretti, Jessica R.; Fischer, Monika
• Is Part Of: Expert opinion on biological therapy. Volume 19:Number 12(2019)
• Page Start: 1343
• Page End: 1355
• Publication Date: 2019-12-02
• Subjects: Adverse events -- dysbiosis -- fecal microbiota transplantation -- intestinal microbiome -- probiotics; Gene therapy -- Periodicals; Protein drugs -- Periodicals; Peptide drugs -- Periodicals; Immunotherapy -- Periodicals; Drug delivery systems -- Periodicals; 615.5
• DOI: 10.1080/14712598.2019.1673725
• Languages: English
• ISSNs: 1471-2598

Abstract

ABSTRACT: Introduction : Alteration in the intestinal microbiota also termed as intestinal dysbiosis has been demonstrated in numerous gastrointestinal disorders linked to aberrant immune processes, acquisition of pathogenic organisms and often administration of antibiotics. Restoration of microbiota through probiotics and fecal microbiota transplantation (FMT) has gained tremendous popularity among researchers in the prevention and treatment of gastrointestinal diseases. Areas covered : In this review, studies testing the safety and efficacy of probiotics and FMT for the treatment of various infectious and inflammatory luminal gastrointestinal diseases are reviewed. Randomized control studies are given priority while important uncontrolled studies are also highlighted. Expert opinion : Probiotics have demonstrated efficacy in the prevention of antibiotic-associated diarrhea and in the eradication of Helicobacter pylori infection. Their utility in the primary and secondary prevention of Clostridioides difficile infection is debatable. The future of medicine should bring forth a personalized approach to probiotic use. FMT has revolutionized the treatment of recurrent CDI as well as severe and fulminant CDI. At the same time, it has galvanized gut microbiota research in the last decade. While FMT in ulcerative colitis appears promising, further studies on the durability and long-term safety are needed before it can be recommended in clinical practice.